Evaluating Fluoxetine’s Growth-Inhibitory Impact on Clinical Isolates of Enteric Bacteria: Harnessing Repurposing Potential. Microbiological & Immunological Communications, [S. l.], v. 2, n. 2, p. 89–96, 2023. DOI: 10.55627/mic.002.02.0454. Disponível em: https://rootspress.org/journals/index.php/MIC/article/view/454. Acesso em: 6 may. 2026.